Jessica A. Kahn, MD, MPH

Associate Chair, Academic Affairs and Career Development

Director, Office of Academic Affairs and Career Development

Academic Affiliations

Professor, UC Department of Pediatrics

Phone 513-636-7764

Email lydia.west@cchmc.org

Clinical

Sexual and reproductive health; eating disorders; cancer prevention behaviors in adolescents

 

Research

Interdisciplinary clinical and epidemiologic studies related to prevention of cervical cancer and other diseases caused by human papillomavirus (HPV), in the United States and globally

Visit the Kahn Lab.

 

Jessica A Kahn, MD, MPH, is a professor of pediatrics in the Division of Adolescent and Transition Medicine at Cincinnati Children's Hospital Medical Center within the University of Cincinnati College of Medicine in Cincinnati, Ohio. Dr. Kahn serves as the director of the Office of Academic Affairs and Career Development at Cincinnati Children’s. She also serves as the associate program director of the Cincinnati Center for Clinical and Translational Science and Training (CCTST) KL2 program and the Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) K12 program at Cincinnati Children's and the University of Cincinnati College of Medicine.

Dr. Kahn sees patients at Cincinnati Children's Hospital Medical Center, both at the main hospital site and at Cincinnati Children's Liberty campus. Her clinical interests include sexual and reproductive health and eating disorders. Her research interests include human papillomavirus (HPV) and Pap tests in adolescent girls, HPV vaccines, and cancer prevention behaviors in adolescents.

Dr. Kahn received her undergraduate degree in architecture from Princeton University in Princeton, New Jersey in 1986. She received her MD from Harvard Medical School in Boston, Massachusetts in 1992 and her MPH from the Harvard School of Public Health in Boston, Massachusetts in 1999. She was chief resident in pediatrics and a fellow in adolescent medicine at the Children's Hospital in Boston, Massachusetts, as well as a clinical fellow and instructor at Harvard Medical School.

Dr. Kahn's awards include the Huffman-Capraro Young Investigator Award from the North American Society for Pediatric and Adolescent Gynecology and the New Investigator Award from the Society for Adolescent Medicine. She has received research grants from the National Institutes of Health, the World Health Organization, and foundations such as the American Cancer Society. She has published approximately 140 articles, and is a contributing author for several medical textbooks. She serves on national and international committees and advisory groups focusing on vaccines and other adolescent health issues.

BArch: Princeton University, Princeton, NJ, 1986.

MD: Harvard Medical School, Boston, MA, 1992.

MPH: Harvard School of Public Health, Boston, MA, 1999.

Residency: Pediatrics, Children's Hospital, Boston, MA, 1995; Chief Resident, Pediatrics, Children's Hospital, Boston, MA, 1996.

Fellowship: Adolescent Medicine, Children's Hospital, Boston, MA, 1999.

Certification: American Board of Pediatrics, 1995; American Board of Pediatrics, subspecialist in Adolescent Medicine, 1999.

View PubMed Publications

Drolet M, Bénard E, Boily M, Ali H, Baandrup L, Bauer H, Beddows S, Brisson J, Brotherton J, Cummings T, Donovan B, Fairley CK, Flagg EW, Johnson AM, MD, Kahn JA, Kavanagh K, Kjaer SK, Kliewer EV Lemieux-Mellouki P, Markowitz L, Mboup A, Mesher D, Niccolai L, Oliphant J, Pollock KG, Soldan K, Sonnenberg P, Tabrizi SN, Tanton C. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2015 May;15(5):565-80.

Mullins TLK, Lally M, Zimet G, Kahn JA. Clinician Attitudes toward CDC Interim Pre-Exposure Prophylaxis (PrEP) Guidance and Operationalizing PrEP for Adolescents. AIDS Patient Care STDS. 2015 Apr;29(4):193-203.

Kahn JA, Rickert VI. Innovative clinical and public health strategies to promote adolescent vaccination. J Adolesc Health. 2015 May;56(5 Suppl):S1-2.

Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML. Behavioral, Immunologic, and Virologic Correlates of Oral Human Papillomavirus Infection in HIV-Infected Youth. Sex Transm Dis. 2015 May;42(5):246-52.

Mayhew A, Mullins TLK, Ding L, Rosenthal SL, Zimet GD, Morrow C, Kahn JA. Risk Perceptions and Subsequent Sexual Behaviors after HPV Vaccination in Adolescents. Pediatrics. 2014 Mar;133(3)401-11.

Vadaparampil ST, Malo TL, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim RG, Bruder KL, Proveaux TM, Zhao X, Halsey NA, Giuliano AR. Physicians’ HPV Vaccine Recommendations at Three and Five Years Post-Vaccine Licensure. Am J Prev Med. 2014 Jan;46(1):80-4.

Kahn JA, Xu J, Kapogiannis BG, Gonin R, Rudy B, Wilson CM, Liu N, Worrell C, Squires KE. Immunogenicity and safety of the HPV -6, -11, -16, -18 Vaccine in HIV-Infected Young Women. Clin Infect Dis. 2013 Sep;57(5):735-44.

Kahn JA, Bernstein DI. HPV vaccination: Too soon for 2 doses? JAMA. 2013 May 1;309(17):1832-4.

Kahn JA, Burk RD, Squires KE, Kapogiannis BG, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson CM. Prevalence and Risk Factors for HPV in HIV-Infected Young Women Receiving Their First HPV Vaccination. J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):390-9.

Kahn JA, Brown DR, Ding L, Widdice LE, Shew ML, Glynn S, Bernstein, DI. Vaccine-Type HPV and Evidence of Herd Immunity after Vaccine Introduction. Pediatrics. 2012 Aug;130(2):e249-56.